These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34140478)

  • 1. BRN2 is a non-canonical melanoma tumor-suppressor.
    Hamm M; Sohier P; Petit V; Raymond JH; Delmas V; Le Coz M; Gesbert F; Kenny C; Aktary Z; Pouteaux M; Rambow F; Sarasin A; Charoenchon N; Bellacosa A; Sanchez-Del-Campo L; Mosteo L; Lauss M; Meijer D; Steingrimsson E; Jönsson GB; Cornell RA; Davidson I; Goding CR; Larue L
    Nat Commun; 2021 Jun; 12(1):3707. PubMed ID: 34140478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
    Zeng H; Jorapur A; Shain AH; Lang UE; Torres R; Zhang Y; McNeal AS; Botton T; Lin J; Donne M; Bastian IN; Yu R; North JP; Pincus L; Ruben BS; Joseph NM; Yeh I; Bastian BC; Judson RL
    Cancer Cell; 2018 Jul; 34(1):56-68.e9. PubMed ID: 29990501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.
    Simmons JL; Pierce CJ; Al-Ejeh F; Boyle GM
    Sci Rep; 2017 Sep; 7(1):10909. PubMed ID: 28883623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.
    Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG
    EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF
    Smith MP; Rana S; Ferguson J; Rowling EJ; Flaherty KT; Wargo JA; Marais R; Wellbrock C
    Pigment Cell Melanoma Res; 2019 Mar; 32(2):280-291. PubMed ID: 30277012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.
    Herbert K; Binet R; Lambert JP; Louphrasitthiphol P; Kalkavan H; Sesma-Sanz L; Robles-Espinoza CD; Sarkar S; Suer E; Andrews S; Chauhan J; Roberts ND; Middleton MR; Gingras AC; Masson JY; Larue L; Falletta P; Goding CR
    Genes Dev; 2019 Mar; 33(5-6):310-332. PubMed ID: 30804224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.
    Bonvin E; Falletta P; Shaw H; Delmas V; Goding CR
    Mol Cell Biol; 2012 Nov; 32(22):4674-83. PubMed ID: 22988297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
    Perotti V; Baldassari P; Molla A; Vegetti C; Bersani I; Maurichi A; Santinami M; Anichini A; Mortarini R
    Oncogene; 2016 Jun; 35(22):2862-72. PubMed ID: 26387540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation.
    Vachtenheim J; Ondrušová L
    Exp Dermatol; 2015 Jul; 24(7):481-4. PubMed ID: 25866058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma.
    Jain A; Tripathi R; Turpin CP; Wang C; Plattner R
    Oncogene; 2017 Aug; 36(32):4585-4596. PubMed ID: 28368422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells.
    Ellmann L; Joshi MB; Resink TJ; Bosserhoff AK; Kuphal S
    Lab Invest; 2012 Dec; 92(12):1788-800. PubMed ID: 23069940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
    Boyle GM; Woods SL; Bonazzi VF; Stark MS; Hacker E; Aoude LG; Dutton-Regester K; Cook AL; Sturm RA; Hayward NK
    Pigment Cell Melanoma Res; 2011 Jun; 24(3):525-37. PubMed ID: 21435193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRN2 and MITF together impact AXL expression in melanoma.
    Simmons JL; Neuendorf HM; Boyle GM
    Exp Dermatol; 2022 Jan; 31(1):89-93. PubMed ID: 33119145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.
    Berlin I; Denat L; Steunou AL; Puig I; Champeval D; Colombo S; Roberts K; Bonvin E; Bourgeois Y; Davidson I; Delmas V; Nieto L; Goding CR; Larue L
    Mol Cell Biol; 2012 Apr; 32(7):1237-47. PubMed ID: 22290434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
    Kundu A; Quirit JG; Khouri MG; Firestone GL
    Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
    Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
    Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.
    Laurette P; Coassolo S; Davidson G; Michel I; Gambi G; Yao W; Sohier P; Li M; Mengus G; Larue L; Davidson I
    Cell Death Differ; 2020 Jan; 27(1):29-43. PubMed ID: 31065107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
    Bonet C; Luciani F; Ottavi JF; Leclerc J; Jouenne FM; Boncompagni M; Bille K; Hofman V; Bossis G; Marco de Donatis G; Strub T; Cheli Y; Ohanna M; Luciano F; Marchetti S; Rocchi S; Birling MC; Avril MF; Poulalhon N; Luc T; Hofman P; Lacour JP; Davidson I; Bressac-de Paillerets B; Ballotti R; Marine JC; Bertolotto C
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected High Levels of BRN2/POU3F2 Expression in Human Dermal Melanocytic Nevi.
    Chitsazan A; Lambie D; Ferguson B; Handoko HY; Gabrielli B; Walker GJ; Boyle GM
    J Invest Dermatol; 2020 Jun; 140(6):1299-1302.e4. PubMed ID: 31881210
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma.
    Scortegagna M; Ruller C; Feng Y; Lazova R; Kluger H; Li JL; De SK; Rickert R; Pellecchia M; Bosenberg M; Ronai ZA
    Oncogene; 2014 Aug; 33(34):4330-9. PubMed ID: 24037523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.